BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17607309)

  • 1. Treatment of an acute severe central neuropathic pain syndrome by topical application of lidocaine 5% patch: a case report.
    Hans GH; Robert DN; Van Maldeghem KN
    Spinal Cord; 2008 Apr; 46(4):311-3. PubMed ID: 17607309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lidocaine 5% patch for localized chronic neuropathic pain in adolescents: report of five cases.
    Nayak S; Cunliffe M
    Paediatr Anaesth; 2008 Jun; 18(6):554-8. PubMed ID: 18363625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term treatment of neuropathic pain with a 5% lidocaine medicated plaster.
    Wilhelm IR; Tzabazis A; Likar R; Sittl R; Griessinger N
    Eur J Anaesthesiol; 2010 Feb; 27(2):169-73. PubMed ID: 20010108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale.
    Argoff CE; Galer BS; Jensen MP; Oleka N; Gammaitoni AR
    Curr Med Res Opin; 2004; 20 Suppl 2():S21-8. PubMed ID: 15563743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lidocaine 5% Medicated Plaster for Spinal Neuropathic Pain.
    Freo U; Ambrosio F; Furnari M; Ori C
    J Pain Palliat Care Pharmacother; 2016 Jun; 30(2):111-3. PubMed ID: 27018847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction: chronic pain studies of the lidocaine patch 5% using the Neuropathic Pain Scale.
    Jensen MP
    Curr Med Res Opin; 2004; 20 Suppl 2():S1-4. PubMed ID: 15563740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Topical pharmacologic approach with 5% lidocaine medicated plaster in the treatment of localized neuropathic pain].
    Provinciali L; Lattanzi S; Chiarlone R; Fogliardi A; Intelligente F; Irace C; Lanzilotta M; Palomba R; Storelli E; Zampi M
    Minerva Med; 2014 Dec; 105(6):515-27. PubMed ID: 25392960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical acetylsalicylic acid versus lidocaine for postherpetic neuralgia: results of a double-blind comparative clinical trial.
    Tajti J; Szok D; Vécsei L
    Neurobiology (Bp); 1999; 7(2):103-8. PubMed ID: 10591045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin biopsy and quantitative sensory testing do not predict response to lidocaine patch in painful neuropathies.
    Herrmann DN; Pannoni V; Barbano RL; Pennella-Vaughan J; Dworkin RH
    Muscle Nerve; 2006 Jan; 33(1):42-8. PubMed ID: 16228968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conclusions: chronic pain studies of lidocaine patch 5% using the Neuropathic Pain Scale.
    Argoff CE
    Curr Med Res Opin; 2004; 20 Suppl 2():S29-31. PubMed ID: 15563744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lidocaine patch: a useful addition to the pain clinic armamentarium.
    Burgess C; Ravenscroft AJ
    Anaesthesia; 2006 Apr; 61(4):412. PubMed ID: 16548983
    [No Abstract]   [Full Text] [Related]  

  • 12. [Relief of subacute herpetic pain and postherpetic neuralgia with repeated application of 10% lidocaine cream].
    Iseki M; Mitsuhata H; Miyazaki T; Toriumi E; Yoshino K
    Masui; 2000 Nov; 49(11):1204-9. PubMed ID: 11215225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New analgesics for neuropathic pain: the lidocaine patch.
    Argoff CE
    Clin J Pain; 2000 Jun; 16(2 Suppl):S62-6. PubMed ID: 10870742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Localized neuropathic pain--5% lidocaine medicated patch as a first-line treatment and as add-on therapy: literature review and personal experience].
    Casale R; Polati E; Schweiger V; Coluzzi F; Bhaskar A; Consalvo M
    Minerva Med; 2014 Jun; 105(3):177-95. PubMed ID: 24988084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and safety of lidocaine patch 5%.
    Galer BS
    J Fam Pract; 2002 Oct; 51(10):867-8; author reply 868. PubMed ID: 12401158
    [No Abstract]   [Full Text] [Related]  

  • 16. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia.
    Rowbotham MC; Davies PS; Verkempinck C; Galer BS
    Pain; 1996 Apr; 65(1):39-44. PubMed ID: 8826488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical lidocaine gel relieves postherpetic neuralgia.
    Rowbotham MC; Davies PS; Fields HL
    Ann Neurol; 1995 Feb; 37(2):246-53. PubMed ID: 7847866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathecal methylprednisolone for intractable postherpetic neuralgia.
    Kotani N; Kushikata T; Hashimoto H; Kimura F; Muraoka M; Yodono M; Asai M; Matsuki A
    N Engl J Med; 2000 Nov; 343(21):1514-9. PubMed ID: 11087880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clarifying the use of lidoderm patch to treat pain associated with postherpetic neuralgia.
    Alvarez NA
    Reg Anesth Pain Med; 2004; 29(1):75; author reply 75. PubMed ID: 14727292
    [No Abstract]   [Full Text] [Related]  

  • 20. 5% lidocaine medicated plaster use in children with neuropathic pain from burn sequelae.
    Orellana Silva M; Yañez V; Hidalgo G; Valenzuela F; Saavedra R
    Pain Med; 2013 Mar; 14(3):422-9. PubMed ID: 23279572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.